Background image pattern

Thesis

Biology is entering a new era of rapid innovation, driven by advances in  molecular biology and computing power.

Hana Faulds looking through a microscope in lab environment

Our Thesis

Empowering
Biotech Innovation

The 1970s saw the creation of the world’s first recombinant human protein (insulin), sparking a global industry now worth over US$35 billion. Today, applied biotech is expanding rapidly across food, biomaterials, medicine, and even the gradual replacement of traditional industrial processes.

In 2003, the Craig Venter-led Human Genome Project was completed, mapping all human genes through an international effort. This breakthrough unlocked genomics, bioinformatics, and synthetic biology, deepening our understanding of the biological code that underpins all life.

Cost of DNA Sequencing Graph showing a downward trend

Cost of DNA Sequencing

The last decade has seen the economics of biotech fundamentally change. The exponential pace of advancement in information technologies is impacting the costs of performing basic biotech research. The cost of sequencing DNA has fallen by a factor 160 000x since 2001 and continues to fall.

Data Processing Power Graph showing increasing trend

Data Processing Power

Parallel to the drastically decreasing costs associated with DNA sequencing, our ability to understand the vast amounts of data being produced is ever improving. This is mainly due to the rapid advancements in the field of bioinformatics and, in particular, artificial intelligence and machine learning.

Number of Publications Citing Gene Editing trending upward graph

Number of Publications Citing Gene Editing

The ability to make precise, targeted changes to the genome was a long-standing goal in biomedical research. This was achieved in 2007 with the development of CRISPR-Cas9, which has since been refined to enable fast, efficient, and low-cost DNA editing.

The existence of these three elements demonstrates the macro trends behind what OneBio believes is about to usher in the “Age of Biology”. Today, biology is like computing in the late 1980s. It is now possible to build biotech companies at an investment level that’s competitive with software startups.

Innovative Solutions for
Human Animal Planetary Health

From diagnostics and therapeutics to the future of food, we back founders solving real problems.